Elevated Levels of Hemoglobin A1c Are Associated With Cerebral White Matter Disease in Patients With Stroke [Clinical Sciences]

Conclusions— Among known risk factors, higher levels of HbA1c were associated with cerebral WMD in stroke patients. This may suggest that chronic disturbance of glycemia measured by HbA1c plays a role in the pathophysiology of WMD. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00715533.
Source: Stroke - Category: Neurology Authors: Tags: Cerebrovascular disease/stroke, Glucose intolerance, CT and MRI Clinical Sciences Source Type: research